Posted in | News | Ceramic Materials | Minerals

Alcan to Invest $129m in Expansion of Brazillian Alumina Refinery

Alcan Inc. announced today that it will proceed with an investment of approximately US$129 million for its participation in the 2.1 million metric tonne per year (Mtpy) expansion of the Alumar consortium alumina refinery in São Luís, State of Maranhão, Brazil. The expanded refinery, in which Alcan has a 10 percent stake, will have a total capacity of approximately 3.5 Mtpy once completed.

"This investment is fully aligned with Alcan's value maximization strategy, which involves growing alumina revenues through the expansion of large-scale, cost-advantaged assets," said Jacynthe Côté, President and Chief Executive Officer, Alcan Bauxite and Alumina. "With increasing global demand for alumina, this investment will boost Alcan's access to a competitive source of alumina in the Atlantic region," Côté added.

The Alumar refinery is already best-in-class in terms of conversion costs, and also has an excellent track record in the area of sustainability, including environment, health and safety. "Its superior performance in these areas is closely aligned with Alcan's commitment to pursue business opportunities that strengthen Alcan's ability to provide a prosperous and sustainable environment for future generations," continued Côté.

The expansion, which will begin operation in the first half of 2008, will increase Alcan’s overall alumina capacity by 210 thousand tonnes per year. With Alcan, the Alumar refinery is jointly owned by Alcoa (54 percent) and BHP Billiton (36 percent).

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.